Information technology in India has become the quintessential example of outsourcing, but companies are emerging all over the world to handle specific tasks at lower costs and with higher expertise.
This phenomenon has manifested in the health care sector, and France is benefiting from its success as a destination for outsourcing in a specialized biotechnology field, said Michel Abiteboul.
Dr. Abiteboul, a medical doctor and an experienced businessman, manages the France activities of a North Carolina-based CRO, or contract research organization.
These niche firms are hired, often by larger pharmaceutical companies, to perform one of the most critical tasks in developing any new drug or medication: human testing through clinical trials.
Dr. Abiteboul is also president of L'Association Francaise des CROs, or AFCROs, which he and others started about seven years ago to represent the interests of CROs and foster a positive environment for clinical trials in France.
In this video interview with GlobalAtlanta, he talks about the organization's objectives and how countries will need to alter their educational policies to lay the groundwork for science-literate societies.
Dr. Abiteboul is considering attending the BIO 2009 International Convention, which will be held in Atlanta beginning May 18. For the full story, click here.
